EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Lethargy With Reversible Bilateral Basal Ganglia and Substantia Nigra Lesions in Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report

Daisuke Abe, Masaoki Hidaka, Masaya Kumamoto, Yuka Kanazawa, Hitonori Takaba

Cureus · 30.07.2026

DOI: 10.7759/cureus.113647 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 30.07.2026. Verfasst von Daisuke Abe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cerebrovascular Medicine and Neurology, Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, JPN. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

anti-n-methyl-d-aspartate receptor encephalitisbasal gangliacyclophosphamide pulseovarian teratomasubstantia nigra

Autor:innen und Institutionen

  • Department of Cerebrovascular Medicine and Neurology, Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, JPN.

Zitieren

APA

Abe, D., Hidaka, M., Kumamoto, M., Kanazawa, Y., & Takaba, H. (2026). Lethargy With Reversible Bilateral Basal Ganglia and Substantia Nigra Lesions in Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report. Cureus. https://doi.org/10.7759/cureus.113647

Vancouver

Abe D, Hidaka M, Kumamoto M, Kanazawa Y, Takaba H. Lethargy With Reversible Bilateral Basal Ganglia and Substantia Nigra Lesions in Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report. Cureus. 2026. doi:10.7759/cureus.113647

BibTeX
@article{Abe2026,
  author = {Abe, Daisuke and Hidaka, Masaoki and Kumamoto, Masaya and Kanazawa, Yuka and Takaba, Hitonori},
  title = {Lethargy With Reversible Bilateral Basal Ganglia and Substantia Nigra Lesions in Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.113647}
}
Kostenlos starten →